Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 45 (ZBTB45) is a transcription factor containing a BTB/POZ domain at the N-terminus and multiple C2H2-type zinc finger domains at the C-terminus[1][2]. It enables sequence-specific DNA binding and is involved in negative regulation of gene transcription, as well as regulation of cytokine production and immune system processes[2]. In the central nervous system, ZBTB45 is expressed ubiquitously during development and is critical for the differentiation of neural stem cells, especially in the glial lineage, influencing both astrocyte and oligodendrocyte precursor fate[1]. Knockdown of ZBTB45 impairs oligodendrocyte maturation and skews neural stem cells toward astrocytic differentiation, highlighting its key role in proper CNS development[1]. The gene is located in a chromosome region frequently deleted in gliomas, suggesting disease relevance, but no directly interacting drugs or specific biomarker or safety concern information is currently available in public databases[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 45 (ZBTB45).